A scientific detective story unearths how SARS-CoV-2 evolves new variants that evade antibodies Credit: Kevin McCarthy and Paul Duprex PITTSBURGH, Feb. 3, 2020 – In a...
The lack of face-to-face meetings during the Covid-19 pandemic caused the U.S. Food and Drug Administration to implement regulatory workarounds to stay on top of drug...
Stay-at-home orders, school closures and other pandemic measures mean that parents and children are spending inordinate amounts of time together. Here's how to deal with the...
New research findings correlate with clinical observations of more fetal abnormalities and other Zika-related health problems in late versus early pregnancy Credit: Photo courtesy of USF...
Immuneering uses bioinformatically tuned target identification and hit finding platforms to generate drug candidates that can tamp down aberrant signalling. The post Disease Cancelling Technology Emulates...
Where conventional mass spec struggles with sequencing and the recognition of isoforms and post-translational modifications, new technologies may shine. The post Proteomics Begins to Emerge from...
New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic
Adamas Pharmaceuticals’ Parkinson’s drug Gocovri has a new indication as an adjunctive treatment for levodopa/carbodopa in patients with The post Competition for Neurocrine as Gocovri picks...
Bristol-Myers Squibb’s commercial hopes for new multiple sclerosis drug Zeposia have yet to bear fruit thanks to the The post BMS eyes May FDA verdict for...
Mental health and wellness platform Modern Health has bought the San Francisco-based mental health startup Kip for an The post Modern Health buys mental health startup...
Credit: The Grainger College of Engineering As the numbers of those infected with COVID-19 has continued to climb, the desperate need for a vaccine was apparent....
Gilead Sciences inked a collaboration, option and license deal with Gritstone Oncology to create a vaccine-based immunotherapy as a cure for HIV.
A potent coronavirus variant originating in South Africa and possibly resistant to current vaccines and antibody treatments was detected for the first time in the United...
When mixed with fluid from a nasal swab or blood sample, these protein sensors emit light within minutes. Credit: Ian Haydon/UW Medicine Institute for Protein Design...
An early Snapchat employee who once architected the “Our Stories” product, Chloë Drimal, has now launched her own social app, Yoni Circle. Described as a membership-based...
Engineers and oncologists teamed to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes Credit: Image courtesy...
The cybersecurity market size is headed for $248 Billion by 2023. “The smartest person in the room” outlines challenges and opportunities. Could Vulnerability, AI Fuzzing, Smart...
Much of the attention on Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca has been on their Covid-19 vaccine efforts, and here is a look at what else...
Credit: Helmholtz Zentrum München Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum Muenchen, the Technical University...
Eli Lilly said new data showed that treatment with 2 of its antibody therapies lowered COVID-19-related hospitalizations & deaths in high-risk patients by 70%.
Eli Lilly and Regeneron have reported results from new studies that show positive results in people at high risk of infection.
AstraZeneca is playing catch up with Eli Lilly and Regeneron with its antibody therapy for COVID-19, but aims The post AZ deploys mobile sites to test...
Twitter announced yesterday that it has acquired newsletter startup Revue for an undisclosed fee. Revue is a free service that allows anyone to start and publish...
As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial The post Unlocking health data to improve oncology...
Eli Lilly and Co. will move a new Covid-19 antibody therapy to human trials targeting a coronavirus variant that was first found in South Africa
Eli Lilly and Co.’s combination antibody drug helped reduce the risk of hospitalization and death in Covid-19 patients by 70%, the drugmaker said, citing early data...
Around 60 million people have had their sense of smell affected by COVID.
Novartis has said that its investment in digital technology has helped it to ride out the worst of The post Novartis hails digital strategy as profits...
Dr. Robert Ben of uOttawa’s Department of Chemistry leads multi-million-dollar initiative that thwarts ice growth to preserve samples for future use Credit: Courtesy University of Ottawa...
The COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have The post Real-world evidence: breaking boundaries in rare...